{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:53:58Z","timestamp":1785228838715,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007951","name":"Tokyo Medical and Dental University","doi-asserted-by":"publisher","award":["2018A2536"],"award-info":[{"award-number":["2018A2536"]}],"id":[{"id":"10.13039\/501100007951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007951","name":"Tokyo Medical and Dental University","doi-asserted-by":"publisher","award":["2016G012"],"award-info":[{"award-number":["2016G012"]}],"id":[{"id":"10.13039\/501100007951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007951","name":"Tokyo Medical and Dental University","doi-asserted-by":"publisher","award":["2017G514"],"award-info":[{"award-number":["2017G514"]}],"id":[{"id":"10.13039\/501100007951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150617","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T17:11:39Z","timestamp":1724865099000},"page":"150617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Structural basis for the full and partial agonist activities of retinoid X receptor \u03b1 ligands with an iso-butoxy and an isopropyl group"],"prefix":"10.1016","volume":"734","author":[{"given":"Daisuke","family":"Imai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-9792","authenticated-orcid":false,"given":"Nobutaka","family":"Numoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Tokiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-0384","authenticated-orcid":false,"given":"Nobutoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150617_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","article-title":"Nuclear receptors, RXR, and the big bang","volume":"157","author":"Evans","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150617_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0092-8674(86)90339-9","article-title":"Functional domains of the human glucocorticoid receptor","volume":"46","author":"Giguere","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150617_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/320134a0","article-title":"Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A","volume":"320","author":"Green","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150617_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(86)90659-8","article-title":"Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA","volume":"46","author":"Miesfeld","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150617_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","article-title":"The nuclear receptor ligand-binding domain: structure and function","volume":"10","author":"Moras","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.150617_bib6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/med.21578","article-title":"A review of the molecular design and biological activities of RXR agonists","volume":"39","author":"de Almeida","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2024.150617_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2217\/imt.13.15","article-title":"Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides","volume":"5","author":"Pileri","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bbrc.2024.150617_bib8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fimmu.2019.01070","article-title":"Nuclear receptors regulate intestinal inflammation in the Context of IBD","volume":"10","author":"Klepsch","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.150617_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3816\/CLM.2003.n.006","article-title":"Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma","volume":"3","author":"Sherman","year":"2003","journal-title":"Clin. Lymphoma"},{"key":"10.1016\/j.bbrc.2024.150617_bib10","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1210\/en.2008-1540","article-title":"Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein","volume":"150","author":"de Vries-van der Weij","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2024.150617_bib11","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0006-2952(01)00803-6","article-title":"Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents","volume":"62","author":"Standeven","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150617_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s001250051193","article-title":"The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction","volume":"42","author":"Lenhard","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2024.150617_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0006-2952(97)00209-8","article-title":"Mitogenic effect of retinoid X receptor agonists in rat liver","volume":"54","author":"Standeven","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150617_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/ml300055n","article-title":"RXR partial agonist CBt-PMN exerts therapeutic effects on type 2 diabetes without the side effects of RXR full agonists","volume":"3","author":"Kakuta","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2024.150617_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1873-3468.13301","article-title":"Dual conformation of the ligand induces the partial agonistic activity of retinoid X receptor alpha (RXRalpha)","volume":"593","author":"Miyashita","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2024.150617_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cmdc.200700313","article-title":"The first potent subtype-selective retinoid X receptor (RXR) agonist possessing a 3-isopropoxy-4-isopropylphenylamino moiety, NEt-3IP (RXRalpha\/beta-dual agonist)","volume":"3","author":"Takamatsu","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbrc.2024.150617_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.715752","article-title":"A retinoid X receptor agonist directed to the large intestine ameliorates T-cell-mediated colitis in mice","volume":"12","author":"Matsumoto","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150617_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/jm501863r","article-title":"RXR partial agonist produced by side chain repositioning of alkoxy RXR full agonist retains antitype 2 diabetes activity without the adverse effects","volume":"58","author":"Kawata","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2024.150617_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch Xds","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bbrc.2024.150617_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Schuttelkopf","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbrc.2024.150617_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1074\/jbc.M113.476861","article-title":"Defining the communication between agonist and coactivator binding in the retinoid X receptor alpha ligand binding domain","volume":"289","author":"Boerma","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150617_bib28","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/emboj\/19.11.2592","article-title":"Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid","volume":"19","author":"Egea","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2024.150617_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1097-2765(00)80448-7","article-title":"Asymmetry in the PPARgamma\/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors","volume":"5","author":"Gampe","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bbrc.2024.150617_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.molcel.2004.11.042","article-title":"A structural basis for constitutive activity in the human CAR\/RXRalpha heterodimer","volume":"16","author":"Xu","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.bbrc.2024.150617_bib31","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1101\/gad.802300","article-title":"Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix","volume":"14","author":"Gampe","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2024.150617_bib32","doi-asserted-by":"crossref","first-page":"24593","DOI":"10.1074\/jbc.M111.245498","article-title":"Structural basis for retinoic X receptor repression on the tetramer","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150617_bib33","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1074\/jbc.M110.166215","article-title":"Danthron functions as a retinoic X receptor antagonist by stabilizing tetramers of the receptor","volume":"286","author":"Zhang","year":"2011","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24011537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24011537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T19:31:51Z","timestamp":1732649511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24011537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S0006291X24011537"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150617","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for the full and partial agonist activities of retinoid X receptor \u03b1 ligands with an iso-butoxy and an isopropyl group","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150617"}}